The Board of Directors of Amplifon S.p.A. (EXM; Bloomberg/Reuters ticker: AMP/AMPF.MI), the global leader in hearing care solutions and services, met today in an extraordinary meeting chaired by Susan Carol Holland and resolved:

(i)            to propose to the Extraordinary Shareholders’ Meeting of the Company, in line with the announcement made on March 16^th, 2026, the approval of the previously announced share capital increase, excluding pre-emption rights pursuant to Article 2441, paragraph 5, of the Italian Civil Code, through the issuance of 56,000,000 new ordinary shares reserved for subscription by GN Store Nord A/S (“GN”), in connection with the acquisition of its entire Hearing business (“GN Hearing” and the “Acquisition”);

(ii)           to propose to the Ordinary Shareholders’ Meeting that the Board of Directors be integrated through (a) the confirmation of the appointment by co-option of Ms. Francesca Fiore and (b) the appointment, subject to the closing of the Acquisition, of Mr. Scott Davis as GN’s representative;

(iii)          to propose to the Extraordinary Shareholders’ Meeting certain amendments to the Articles of Association in order to align them with the provisions introduced by Legislative Decree No. 47 of March 27^th, 2026 (the “Decree”), issued in implementation of Law No. 21 of March 5^th, 2024 (the “Capital Markets Law”); and

(iv)          to give final approval to the partial demerger by way of a spin-off pursuant to Article 2506.1 of the Italian Civil Code (the “Demerger”), announced on July 30^th, 2026, aimed at making the Group’s corporate structure more efficient.

The Board of Directors also resolved to convene the Extraordinary and Ordinary Shareholders’ Meeting, on first and single call, to resolve on the matters referred to above, granting the Chief Executive Officer and the Chair, severally, the authority to determine the date of the meeting.